News

PharmExec7h
FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
FDA approves Novavax COVID-19 shot but with unusual restrictions
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
STAT10h
When the FDA requires a large vaccine trial, who pays?
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
RFK Jr. pledged not to upend US vaccine system, but big changes are underway
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...